Ocular Therapeutix, Inc financial data

Symbol
OCUL on Nasdaq
Industry
Pharmaceutical Preparations
Location
15 Crosby Drive, Bedford, Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
Former names
I-THERAPEUTIX INC (to 7/2/2009)
Latest financial report
Q1 2024 - May 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 785 % +68.5%
Quick Ratio 7.38 % +17.9%
Debt-to-equity 111 % -61.5%
Return On Equity -90.4 % +60%
Return On Assets -42.9 % +26.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 149 M shares +91.8%
Common Stock, Shares, Outstanding 155 M shares +99.6%
Entity Public Float 406 M USD +42.9%
Common Stock, Value, Issued 15 K USD +87.5%
Weighted Average Number of Shares Outstanding, Basic 132 M shares +70.6%
Weighted Average Number of Shares Outstanding, Diluted 132 M shares +70.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 59.8 M USD +15.8%
Research and Development Expense 67 M USD +21.7%
Selling and Marketing Expense 39.9 M USD -4.31%
General and Administrative Expense 39 M USD +15.3%
Costs and Expenses 151 M USD +12%
Operating Income (Loss) -91.5 M USD -9.69%
Nonoperating Income (Expense) -23.8 M USD -337%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -115 M USD -29.8%
Earnings Per Share, Basic -1.11 USD/shares +3.48%
Earnings Per Share, Diluted -1.12 USD/shares +1.75%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 483 M USD +511%
Accounts Receivable, after Allowance for Credit Loss, Current 26.5 M USD +25.7%
Inventory, Net 2.57 M USD +13.6%
Assets, Current 520 M USD +385%
Property, Plant and Equipment, Net 11.5 M USD -4.76%
Operating Lease, Right-of-Use Asset 6.06 M USD -20.5%
Assets 539 M USD +319%
Accounts Payable, Current 6.45 M USD +18.6%
Employee-related Liabilities, Current 5.37 M USD +18.6%
Accrued Liabilities, Current 16 M USD -27.1%
Contract with Customer, Liability, Current 263 K USD -43.2%
Liabilities, Current 24.3 M USD -18.2%
Contract with Customer, Liability, Noncurrent 14.1 M USD +5.46%
Operating Lease, Liability, Noncurrent 6.41 M USD -21%
Other Liabilities, Noncurrent 111 K USD +11%
Liabilities 131 M USD +10.2%
Retained Earnings (Accumulated Deficit) -762 M USD -17.8%
Stockholders' Equity Attributable to Parent 408 M USD +4101%
Liabilities and Equity 539 M USD +319%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -33.9 M USD -69.7%
Net Cash Provided by (Used in) Financing Activities 321 M USD +411724%
Net Cash Provided by (Used in) Investing Activities -255 K USD +92.5%
Common Stock, Shares Authorized 200 M shares 0%
Common Stock, Shares, Issued 155 M shares +99.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 287 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 485 M USD +500%
Interest Paid, Excluding Capitalized Interest, Operating Activities 13 M USD +1750%
Deferred Tax Assets, Valuation Allowance 184 M USD +11.7%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 195 M USD +15.5%
Operating Lease, Liability 8.46 M USD -17.6%
Payments to Acquire Property, Plant, and Equipment 255 K USD -92.5%
Lessee, Operating Lease, Liability, to be Paid 10.7 M USD -21.6%
Property, Plant and Equipment, Gross 32 M USD +17.9%
Operating Lease, Liability, Current 1.54 M USD -15.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.67 M USD -4.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.5 M USD -5.97%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure -7.46%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.25 M USD -33.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.71 M USD +1.31%
Deferred Tax Assets, Operating Loss Carryforwards 121 M USD +6.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5 M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.11 M USD -22.1%
Operating Lease, Payments 2.66 M USD +4.47%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 920 K USD +90.5%
Deferred Tax Assets, Net of Valuation Allowance 10.8 M USD +174%
Share-based Payment Arrangement, Expense 21.2 M USD +22.5%
Interest Expense 13.6 M USD +91.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%